RELX PLC operates as an information and analytics company serving professional and business markets across North America, Europe, and internationally. The company provides data-driven decision tools and content platforms that combine proprietary datasets with technology and algorithmic capabilities to address specific sector needs.
The company segments its operations into four primary divisions. The Risk segment delivers analytics and predictive tools for risk evaluation, along with commercial healthcare products. The Scientific, Technical & Medical segment supplies scientific and medical information resources for research and healthcare applications. The Legal segment offers legal, regulatory, and business information analytics. The Exhibitions segment combines digital and in-person networking platforms, enabling customers to discover markets, source products, and generate business leads.
With approximately 35,700 full-time employees, RELX maintains a substantial global footprint from its London headquarters. The company was incorporated in 1903 and rebranded from Reed Elsevier PLC to RELX PLC in 2015, reflecting a strategic shift toward its analytics and decision-tool offerings. The company trades on the New York Stock Exchange and serves enterprise and professional customers requiring specialized information and analytical capabilities across risk management, scientific research, legal practice, and business-to-business networking.
No 10-K filings found.